Unmasking a hidden threat for optimal ALL treatment in children

Asparaginase (ASNase) remains a cornerstone of chemo regimens for ALL. But there’s a quiet threat that’s often missed: hypersensitivity reactions to E. coli ASNase, particularly its pegylated form, PEG-ASNase. These allergic reactions may be a common reason patients stop or don’t get optimal dosing.

Read more: https://www.mdlinx.com/article/don-t-miss-this-just-because-it-s-rare-unmasking-a-hidden-threat-for-optimal-all-treatment-in-young/2xgS3zLomZtxgv6pwzMIb3